A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection.
Moss, Ronald B.; Hansen, Carrie; Sanders, Rebecca L.; Hawley, Stephen; Li, Tiejun; Steigbigel, Roy T.; Journal of Infectious Diseases, 2012, vol. 206, issue 12, p 1844, ISSN 00221899. ISBN 15376613.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef